EQL — EQL Pharma AB Share News
0.000.00%
Last trade - 00:00- SEK670.32m
- SEK1.07bn
- SEK432.66m
Brief: EQL Pharma Q3 EBIT Rises To SEK 2.4 Million
Brief: EQL Pharma Gets New Order For Consumables From Hospital Region
Brief: EQL Pharma Q2 EBIT Rises To SEK 3.4 Mln
Brief: EQL Pharma Q1 Operating Profit Rises To SEK 11.6 Mln
Brief: Eql Pharma AB - Gets New Order For Security Gear
Brief: EQL Pharma Q4 EBITDA Up At SEK 1.1 Mln
Brief: EQL Pharma AB - Gets Order From Swedish Healthcare
Brief: EQL Pharma Is Preparing Listing On Nasdaq Stockholm
Brief: EQL Pharma Q2 EBITDA Up At SEK 2.3 Million
Brief: EQL Pharma: Aripiprazol EQL Pharma Approved By The Swedish Medicines Agency For Sale
Brief: EQL Pharma Q4 EBITDA At SEK 0.4 Million
Brief: EQL Pharma Says Methenamine Hippurate EQL Pharma Approved
Brief: EQL Pharma: Mandatory Offer From Fårö Capital
Brief: Eql Pharma's Rights Issue Subscribed To Approximately 161.7 Percent
Brief: EQL Pharma Resolves On A Rights Issue Of Approximately SEK 24.9 mln
Brief: EQL Pharma April-June EBITDA At SEK 0.9 Million
Brief: Eql Pharma AB Drug Acetazolamide Eql Pharma Has Now Been Approved For Sale By Swedish Medicines Agency
Brief: EQL Pharma Jan-March EBITDA Swings To Loss Of SEK 602,000
Brief: EQL Pharma Q3 EBITDA up 120 pct YoY